The study seeks to understand the mechanisms of colorectal cancer and builds on recent Vanderbilt research.
The project seeks to reduce the time for clinical chart abstraction by 90% while maintaining human-level accuracy.
VUMC researchers have developed a genetic method that clusters distantly related people to find rare variants that were present in a common ancestor.
Launched Sept. 17-19 during the World Cancer Congress in Geneva, Switzerland, “Rewriting Cancer” aims to enhance understanding and inspire audiences by exploring the most innovative, inclusive and impactful solutions for cancer prevention, diagnosis, treatment and care globally.
The research focused on the very early stages of FPF, a serious progressive lung disease where for unknown reasons scar tissue builds up in the lungs over time.
Bick will succeed Nancy Cox, PhD, who has led Genetic Medicine since she came to VUMC in 2015. Genetic Medicine is one of 13 divisions in the Department of Medicine.